Literature DB >> 28121511

Update on Trial Registration 11 Years after the ICMJE Policy Was Established.

Deborah A Zarin1, Tony Tse1, Rebecca J Williams1, Thiyagu Rajakannan1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28121511      PMCID： PMC5813248          DOI： 10.1056/NEJMsr1601330

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  50 in total

1.  Registration rates, adequacy of registration, and a comparison of registered and published primary outcomes in randomized controlled trials published in surgery journals.

Authors:  Shane Killeen; Panos Sourallous; Iain A Hunter; John E Hartley; Helen L O Grady
Journal:  Ann Surg       Date:  2014-01       Impact factor: 12.969

2.  Is this trial misreported? Truth seeking in the burgeoning age of trial transparency.

Authors:  Peter Doshi
Journal:  BMJ       Date:  2016-10-24

3.  The ClinicalTrials.gov results database--update and key issues.

Authors:  Deborah A Zarin; Tony Tse; Rebecca J Williams; Robert M Califf; Nicholas C Ide
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

4.  Afamelanotide for Erythropoietic Protoporphyria.

Authors:  Janneke G Langendonk; Manisha Balwani; Karl E Anderson; Herbert L Bonkovsky; Alexander V Anstey; D Montgomery Bissell; Joseph Bloomer; Chris Edwards; Norbert J Neumann; Charles Parker; John D Phillips; Henry W Lim; Iltefat Hamzavi; Jean-Charles Deybach; Raili Kauppinen; Lesley E Rhodes; Jorge Frank; Gillian M Murphy; Francois P J Karstens; Eric J G Sijbrands; Felix W M de Rooij; Mark Lebwohl; Hetanshi Naik; Colin R Goding; J H Paul Wilson; Robert J Desnick
Journal:  N Engl J Med       Date:  2015-07-02       Impact factor: 91.245

5.  Comparison of protocols and registry entries to published reports for randomised controlled trials.

Authors:  Kerry Dwan; Douglas G Altman; Lynne Cresswell; Michaela Blundell; Carrol L Gamble; Paula R Williamson
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

6.  Geographic location of antiretroviral clinical trials in HIV infected pediatric patients.

Authors:  Katie J Suda; Jodie Greene; Chasity M Shelton
Journal:  Int J Clin Pharm       Date:  2013-09-19

7.  Use of ClinicalTrials.gov to estimate condition-specific nocebo effects and other factors affecting outcomes of analgesic trials.

Authors:  M Soledad Cepeda; Victor Lobanov; Jesse A Berlin
Journal:  J Pain       Date:  2013-02-28       Impact factor: 5.820

8.  Selective publication of antidepressant trials and its influence on apparent efficacy.

Authors:  Erick H Turner; Annette M Matthews; Eftihia Linardatos; Robert A Tell; Robert Rosenthal
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

9.  Comparison of Eligibility Criteria Between Protocols, Registries, and Publications of Cancer Clinical Trials.

Authors:  Sheng Zhang; Fei Liang; Wenfeng Li; Ian Tannock
Journal:  J Natl Cancer Inst       Date:  2016-05-25       Impact factor: 13.506

10.  SPIRIT 2013 statement: defining standard protocol items for clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Douglas G Altman; Andreas Laupacis; Peter C Gøtzsche; Karmela Krleža-Jerić; Asbjørn Hróbjartsson; Howard Mann; Kay Dickersin; Jesse A Berlin; Caroline J Doré; Wendy R Parulekar; William S M Summerskill; Trish Groves; Kenneth F Schulz; Harold C Sox; Frank W Rockhold; Drummond Rennie; David Moher
Journal:  Ann Intern Med       Date:  2013-02-05       Impact factor: 25.391
View more
  68 in total

Review 1.  Standards for design and measurement would make clinical research reproducible and usable.

Authors:  Kay Dickersin; Evan Mayo-Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-13       Impact factor: 11.205

2.  Lockbox for Registered Trials of Unapproved Devices.

Authors:  Tony Tse; Annice Bergeris; Deborah A Zarin
Journal:  N Engl J Med       Date:  2018-03-15       Impact factor: 91.245

3.  Comparison of Data on Serious Adverse Events and Mortality in ClinicalTrials.gov, Corresponding Journal Articles, and FDA Medical Reviews: Cross-Sectional Analysis.

Authors:  Richeek Pradhan; Sonal Singh
Journal:  Drug Saf       Date:  2018-09       Impact factor: 5.606

4.  Is it time for computable evidence synthesis?

Authors:  Adam G Dunn; Florence T Bourgeois
Journal:  J Am Med Inform Assoc       Date:  2020-06-01       Impact factor: 4.497

5.  Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR).

Authors:  Rebecca Mercieca-Bebber; Douglas Williams; Margaret-Ann Tait; Jessica Roydhouse; Lucy Busija; Chindhu Shunmuga Sundaram; Michelle Wilson; Ailsa Langford; Claudia Rutherford; Natasha Roberts; Madeleine King; Elisabeth Vodicka; Beth Devine
Journal:  Qual Life Res       Date:  2018-06-18       Impact factor: 4.147

6.  Automatic extraction of quantitative data from ClinicalTrials.gov to conduct meta-analyses.

Authors:  Richeek Pradhan; David C Hoaglin; Matthew Cornell; Weisong Liu; Victoria Wang; Hong Yu
Journal:  J Clin Epidemiol       Date:  2018-09-23       Impact factor: 6.437

7.  Phylotocol: Promoting Transparency and Overcoming Bias in Phylogenetics.

Authors:  Melissa B DeBiasse; Joseph F Ryan
Journal:  Syst Biol       Date:  2019-07-01       Impact factor: 15.683

Review 8.  A review of pragmatic trials found a high degree of diversity in design and scope, deficiencies in reporting and trial registry data, and poor indexing.

Authors:  Stuart G Nicholls; Kelly Carroll; Spencer Phillips Hey; Merrick Zwarenstein; Jennifer Zhe Zhang; Hayden P Nix; Jamie C Brehaut; Joanne E McKenzie; Steve McDonald; Charles Weijer; Dean A Fergusson; Monica Taljaard
Journal:  J Clin Epidemiol       Date:  2021-03-28       Impact factor: 6.437

9.  Patient Participation in Clinical Trials of Oncology Drugs and Biologics Preceding Approval by the US Food and Drug Administration.

Authors:  Nora Hutchinson; Benjamin Carlisle; Adelaide Doussau; Rafia Bosan; Eli Gumnit; Amanda MacPherson; Dean A Fergusson; Jonathan Kimmelman
Journal:  JAMA Netw Open       Date:  2021-05-03

10.  A comparative analysis of important public clinical trial registries, and a proposal for an interim ideal one.

Authors:  Nisha Venugopal; Gayatri Saberwal
Journal:  PLoS One       Date:  2021-05-11       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.